Table 2. Incidence and Outcome of VOD... | American Society of Hematology

Table 2.

Incidence and Outcome of VOD

Incidence of VOD	No. With VOD/No. Evaluated
Whole series	87/1,652 (5.3%)
Autologous BMT	31/1,010 (3.1%)
Syngeneic BMT	0/11
Allogeneic BMT	56/631 (8.9%)
HLA-identical sibling	45/458 (9.8%)
Other relative	2/40 (5.0%)
Unrelated donor	9/133 (6.8%)
Outcome	No./Total
Mild VOD	7/87 (8.0%)
Moderate VOD	56/87 (64.4%)
Severe VOD	24/87 (27.6%)
Death due to VOD	16/87 (18.4%)^*
Not resolved^†	8/87 (9.2%)

Incidence of VOD	No. With VOD/No. Evaluated
Whole series	87/1,652 (5.3%)
Autologous BMT	31/1,010 (3.1%)
Syngeneic BMT	0/11
Allogeneic BMT	56/631 (8.9%)
HLA-identical sibling	45/458 (9.8%)
Other relative	2/40 (5.0%)
Unrelated donor	9/133 (6.8%)
Outcome	No./Total
Mild VOD	7/87 (8.0%)
Moderate VOD	56/87 (64.4%)
Severe VOD	24/87 (27.6%)
Death due to VOD	16/87 (18.4%)^*
Not resolved^†	8/87 (9.2%)

One percent of the whole series; 66.7% of severe VOD.

When the patient died of other causes.